$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000114420417027380 Filed on May 15, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.060M	$1.850M	$1.170M
YoY Change	161.54%	40.15%	-33.52%
% of Gross Profit
Research & Development	$3.090M	$3.439M	$2.650M
YoY Change	16.6%	48.87%	107.03%
% of Gross Profit
Depreciation & Amortization	$280.0K	$282.8K	$260.0K
YoY Change	7.69%	10.31%	420.0%
% of Gross Profit
Operating Expenses	$6.220M	$5.391M	$3.870M
YoY Change	60.72%	45.09%	25.24%
Operating Profit		-$5.391M
YoY Change		45.09%
Interest Expense	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$30.00K	$6.098K
YoY Change		31.42%
Pretax Income	-$6.190M	-$5.380M	-$3.870M
YoY Change	59.95%	45.01%	27.3%
Income Tax
% Of Pretax Income
Net Earnings	-$6.190M	-$5.385M	-$3.870M
YoY Change	59.95%	45.1%	27.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$6.585M	-$6.405M	-$7.442M
COMMON SHARES
Basic Shares Outstanding	47.68M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.490M	$4.440M	$4.060M
YoY Change	10.59%	153.71%	-23.11%
Cash & Equivalents	$4.490M	$4.440M	$4.060M
Short-Term Investments
Other Short-Term Assets	$442.0K	$410.0K	$430.1K
YoY Change	2.77%	41.38%	34.28%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.929M	$4.850M	$4.492M
YoY Change	9.72%	137.73%	-26.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.325M	$5.460M	$5.985M
YoY Change	-11.02%	-10.93%	32.26%
Goodwill
YoY Change
Intangibles	$44.32K	$46.15K	$51.61K
YoY Change	-14.13%
Long-Term Investments
YoY Change
Other Assets	$330.0K	$63.23K	$0.00
YoY Change		-88.71%	-100.0%
Total Long-Term Assets	$5.700M	$5.945M	$6.411M
YoY Change	-11.09%	-11.92%	24.57%
TOTAL ASSETS
Total Short-Term Assets	$4.929M	$4.850M	$4.492M
Total Long-Term Assets	$5.700M	$5.945M	$6.411M
Total Assets	$10.63M	$10.80M	$10.90M
YoY Change	-2.52%	22.81%	-3.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.650M	$1.890M	$1.500M
YoY Change	10.0%	-12.9%	6.38%
Accrued Expenses	$0.00	$0.00	$20.00K
YoY Change	-100.0%	-100.0%	100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$10.00K	$10.00K	$60.00K
YoY Change	-83.33%	-83.33%	0.0%
Long-Term Debt Due	$0.00	$0.00	$20.00K
YoY Change	-100.0%	-100.0%	-77.78%
Total Short-Term Liabilities	$1.771M	$2.020M	$1.731M
YoY Change	2.36%	-16.52%	1.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$304.6K	$314.7K	$400.0K
YoY Change	-23.86%	-26.82%	-16.66%
Total Long-Term Liabilities	$329.6K	$314.7K	$400.0K
YoY Change	-17.6%	-26.82%	-20.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.771M	$2.020M	$1.731M
Total Long-Term Liabilities	$329.6K	$314.7K	$400.0K
Total Liabilities	$2.101M	$2.335M	$2.131M
YoY Change	-1.39%	-18.08%	-3.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$64.32M	-$58.13M	-$44.04M
YoY Change	46.04%		51.31%
Common Stock	$49.23K	$45.45K	$35.11K
YoY Change	40.2%		44.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.528M	$8.460M	$8.773M
YoY Change
Total Liabilities & Shareholders Equity	$10.63M	$10.80M	$10.90M
YoY Change	-2.52%	22.81%	-3.19%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q2
OPERATING ACTIVITIES
Net Income	-$6.190M	-$5.385M	-$3.870M
YoY Change	59.95%	45.1%	27.3%
Depreciation, Depletion And Amortization	$280.0K	$282.8K	$260.0K
YoY Change	7.69%	10.31%	420.0%
Cash From Operating Activities	-$3.640M	-$3.610M	-$3.150M
YoY Change	15.56%	42.13%	60.71%
INVESTING ACTIVITIES
Capital Expenditures	-$110.0K	-$30.00K	-$320.0K
YoY Change	-65.63%	-94.12%	-85.65%
Acquisitions
YoY Change
Other Investing Activities	$20.00K	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$90.00K	-$20.00K	-$310.0K
YoY Change	-70.97%	-96.15%	-86.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.770M	4.500M	5.790M
YoY Change	-34.89%	45.63%	363.2%
NET CHANGE
Cash From Operating Activities	-3.640M	-3.610M	-3.150M
Cash From Investing Activities	-90.00K	-20.00K	-310.0K
Cash From Financing Activities	3.770M	4.500M	5.790M
Net Change In Cash	40.00K	870.0K	2.330M
YoY Change	-98.28%	2800.0%	-179.25%
FREE CASH FLOW
Cash From Operating Activities	-$3.640M	-$3.610M	-$3.150M
Capital Expenditures	-$110.0K	-$30.00K	-$320.0K
Free Cash Flow	-$3.530M	-$3.580M	-$2.830M
YoY Change	24.73%	76.35%	-1148.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	314655	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	400038	USD
CY2017Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	10000	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1500650	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1887726	USD
CY2016Q2	us-gaap	Assets Assets	10903391	USD
CY2017Q1	us-gaap	Assets Assets	10795092	USD
CY2016Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	6411284	USD
CY2017Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	5945492	USD
CY2016Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	375000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	4849600	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	430094	USD
CY2016Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	USD
CY2017Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	119269	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	119688	USD
CY2017Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	45454	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	35114	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66548014	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52782569	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58133226	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44044830	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	8460242	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	8772853	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10795092	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10903391	USD
CY2016Q2	us-gaap	Cash Cash	4062013	USD
CY2017Q1	us-gaap	Cash Cash	4436563	USD
CY2017Q1	us-gaap	Liabilities Liabilities	2334850	USD
CY2016Q2	us-gaap	Liabilities Liabilities	2130538	USD
CY2017Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	382535	USD
CY2016Q1	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	1180350	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46145	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	51614	USD
CY2017Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	375000	USD
CY2016Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	23128	USD
CY2017Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2762	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	15079	USD
CY2017Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	438	USD
CY2016Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11955	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2020195	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1730500	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	314655	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	400038	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4640	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15228	USD
CY2016Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	302731	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	706380	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	448345	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
CY2017Q1	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	1859699	USD
CY2016Q1	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	265470	USD
CY2017Q1	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	163738	USD
CY2016Q1	us-gaap	Manufacturing Costs ManufacturingCosts	461599	USD
CY2017Q1	us-gaap	Professional Fees ProfessionalFees	278031	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	3715475	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	5390697	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3715475	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	940650	USD
CY2017Q1	us-gaap	Manufacturing Costs ManufacturingCosts	994366	USD
CY2016Q1	antb	Investor Relations InvestorRelations	88138	USD
CY2017Q1	antb	Investor Relations InvestorRelations	103657	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6098	USD
CY2016Q1	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	907626	USD
CY2017Q1	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	1187379	USD
CY2016Q1	us-gaap	Professional Fees ProfessionalFees	106791	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5390697	USD
CY2016Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1	USD
CY2017Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	1143	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	0	USD
CY2016Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	5782	USD
CY2017Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	792	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-3710835	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-5384599	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24338219	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42216495	shares
CY2017Q1	antb	Facilities And Other Costs FacilitiesAndOtherCosts	421292	USD
CY2016Q1	antb	Facilities And Other Costs FacilitiesAndOtherCosts	402770	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	3187751	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	5073057	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	869750	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	629996	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	1837110	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	2073503	USD
	antb	Investor Relations InvestorRelations	202458	USD
	antb	Investor Relations InvestorRelations	259192	USD
	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	3025476	USD
	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	3339332	USD
	us-gaap	Professional Fees ProfessionalFees	344964	USD
	us-gaap	Professional Fees ProfessionalFees	564047	USD
	us-gaap	Operating Expenses OperatingExpenses	11081610	USD
	us-gaap	Operating Expenses OperatingExpenses	14103624	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11081610	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14103624	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	965	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
	us-gaap	Interest Expense InterestExpense	4135	USD
	us-gaap	Interest Expense InterestExpense	1595	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	20098	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	11517	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16928	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11064682	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14088396	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24338219	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39446695	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3439095	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2310189	USD
	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-30868	USD
	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-85802	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4940653	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10155177	USD
	antb	Facilities And Other Costs FacilitiesAndOtherCosts	1223847	USD
	antb	Facilities And Other Costs FacilitiesAndOtherCosts	907721	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3761837	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-14935542	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3537963	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5523706	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3106437	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	9053807	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5145032	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	5974385	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5307909	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2929084	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8399343	USD
	antb	Stock Issued During Period Value Conversion Of Note Payable StockIssuedDuringPeriodValueConversionOfNotePayable	59517	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5469	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5469	USD
	us-gaap	Depreciation Depreciation	476941	USD
	us-gaap	Depreciation Depreciation	829258	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2877628	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3537963	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7336591	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9667825	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-3532684	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	374550	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1500	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-2800	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1136746	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	70033	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	23128	USD
	antb	Warrant Expense WarrantExpense	62941	USD
	antb	Warrant Expense WarrantExpense	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	93767	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	233676	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-450167	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q2	us-gaap	Cash Cash	5278706	USD
CY2016Q1	us-gaap	Cash Cash	1746022	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1774413	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	300302	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-112802	USD
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	381676	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10861499	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	683194	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	336929	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	5400	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	312229	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	516550	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	250163	USD
	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	50000	USD
	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	0	USD
	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	9517	USD
	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	0	USD
CY2017Q1	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	438	USD
	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	11517	USD
CY2017Q1	antb	Working Capital Deficit WorkingCapitalDeficit	2829405	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1708508	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	879250	USD
CY2017Q1	us-gaap	Depreciation Depreciation	282829	USD
CY2016Q1	us-gaap	Depreciation Depreciation	256404	USD
	antb	Investor Relations Expense InvestorRelationsExpense	90803	USD
CY2017Q1	antb	Investor Relations Expense InvestorRelationsExpense	33878	USD
CY2014Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4275172	USD
CY2017Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	USD
CY2016Q2	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1.95
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	512820	shares
CY2016Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12915327	USD
CY2016	antb	Fair Value Of Warrants FairValueOfWarrants	11955	USD
	antb	Fair Value Of Warrants FairValueOfWarrants	438	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	AntriaBio, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001509261
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	ANTB
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47678640	shares
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	63233	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45452450	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45452450	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35110916	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35110916	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9000403	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6802332	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1951602	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1405286	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5103221	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4279278	USD
	antb	Warrant Modification Deemed Dividend WarrantModificationDeemedDividend	-3366070	USD
CY2017Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	5306	USD
CY2016Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	0	USD
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	5306	USD
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	0	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8750669	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3772114	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17454466	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11125961	USD
CY2017Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	61279	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	61279	USD
CY2017Q1	antb	Warrant Modification Deemed Dividend WarrantModificationDeemedDividend	-3366070	USD
CY2016Q1	antb	Warrant Modification Deemed Dividend WarrantModificationDeemedDividend	0	USD
	antb	Warrant Modification Deemed Dividend WarrantModificationDeemedDividend	0	USD
	antb	Adjustments To Additional Paid In Capital Warrant Modification AdjustmentsToAdditionalPaidInCapitalWarrantModification	-3366070	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5347615	USD
	antb	Warrantvaluerecordedasdebtdiscount Warrantvaluerecordedasdebtdiscount	3366070	USD
	antb	Warrantvaluerecordedasdebtdiscount Warrantvaluerecordedasdebtdiscount	0	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	61279	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><u>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), and its wholly owned operating subsidiaries, AntriaBio Delaware, Inc. (“Antria Delaware”) and AntriaBio Korea (“Antria Korea”). AntriaBio, Antria Delaware, and Antria Korea are collectively referred to herein as the “Company”.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and impairment of depreciable assets, the fair value of share-based payments and warrants, fair value of derivative instruments, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	11955	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7169622	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6863920	USD
CY2015Q4	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series A Stock had a conversion feature at the option of the holder that could be converted at any time at a conversion rate of $1.95, subject to adjustment, into common stock. The shares also had a mandatory conversion feature at the same conversion rate if one of the following events occurs: 1) Upon vote or consent of 2/3 of the then outstanding Series A Stock; 2) Upon the Companys listing to NASDAQ Stockmarket or the NYSE MKT and the Companys common stock trades for 30 days for at least 155% of the Series A Stock conversion price; or 3) the Company closes an underwritten public offering of at least $15 million in gross proceeds with an offering price of at least 155% of the Series A Stock conversion price. The Series A Stocks conversion price was subject to weighted average anti-dilution protection, as defined, and was subject to adjustments for stock splits, dividends, and similar events.
CY2017Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.65
CY2017Q1	antb	Warrants To Purchase Common Stock Value WarrantsToPurchaseCommonStockValue	15474883	USD
	antb	Warrants Expired To Purchase Of Common Stock WarrantsExpiredToPurchaseOfCommonStock	307261	shares
CY2017Q1	antb	Operating Leases Future Minimum Payments Remainder Of Fiscal Year Gross OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYearGross	170673	USD
CY2017Q1	antb	Operating Leases Future Minimum Payments Due In Two Years Gross OperatingLeasesFutureMinimumPaymentsDueInTwoYearsGross	691422	USD
CY2017Q1	antb	Operating Leases Future Minimum Payments Due In Three Years Gross OperatingLeasesFutureMinimumPaymentsDueInThreeYearsGross	712360	USD
CY2017Q1	antb	Operating Leases Future Minimum Payments Due In Four Years Gross OperatingLeasesFutureMinimumPaymentsDueInFourYearsGross	664696	USD
CY2017Q1	antb	Operating Leases Future Minimum Payments Due In Five Years Gross OperatingLeasesFutureMinimumPaymentsDueInFiveYearsGross	338392	USD
CY2017Q1	antb	Operating Leases Future Minimum Payments Due Thereafter Gross OperatingLeasesFutureMinimumPaymentsDueThereafterGross	917200	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Remainder Of Fiscal Year FutureMinimumSubleaseRentalsSaleLeasebackTransactionsRemainderOfFiscalYear	37570	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears	152005	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears	157187	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears	148551	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears	0	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter	0	USD
CY2017Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions FutureMinimumSubleaseRentalsSaleLeasebackTransactions	495313	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	133103	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	539417	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	555173	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	516145	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	338392	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	917200	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1743838	USD
CY2017Q1	antb	Operating Leases Future Minimum Payments Due Gross OperatingLeasesFutureMinimumPaymentsDueGross	2239151	USD
CY2014Q2	us-gaap	Area Of Land AreaOfLand	27000	sqft
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	28939	USD
CY2014Q2	antb	Payments Of Monthly Lease Adjusted Annually Percentage PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage	0.03	pure
CY2014Q2	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	375000	USD
CY2014Q2	antb	Adjusted Triple Net Expense Of Lease Payments AdjustedTripleNetExpenseOfLeasePayments	34381	USD
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	750000	USD

Files In Submission

Name	View Source	Status
0001144204-17-027380-index-headers.html	Edgar Link	pending
0001144204-17-027380-index.html	Edgar Link	pending
0001144204-17-027380.txt	Edgar Link	pending
0001144204-17-027380-xbrl.zip	Edgar Link	pending
antb-20170331.xml	Edgar Link	completed
antb-20170331.xsd	Edgar Link	pending
antb-20170331_cal.xml	Edgar Link	unprocessable
antb-20170331_def.xml	Edgar Link	unprocessable
antb-20170331_lab.xml	Edgar Link	unprocessable
antb-20170331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v465723_10q.htm	Edgar Link	pending
v465723_ex10-1.htm	Edgar Link	pending
v465723_ex31-1.htm	Edgar Link	pending
v465723_ex31-2.htm	Edgar Link	pending
v465723_ex32-1.htm	Edgar Link	pending
v465723_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2017 Q2 Form 10-Q Financial Statement

#000114420417027380 Filed on May 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2017 Q2 Form 10-Q Financial Statement

#000114420417027380 Filed on May 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt